Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
20 studies found for:    Cad106
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Condition: Alzheimer's Disease
Intervention: Biological: CAD106
2 Completed To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
Condition: Alzheimer Disease
Intervention: Biological: CAD106
3 Completed Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients
Condition: Alzheimer's Disease
Interventions: Biological: Placebo;   Biological: CAD106
4 Completed To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients
Condition: Alzheimer Disease
Intervention: Biological: CAD106
5 Completed Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Biological: CAD106;   Drug: Placebo
6 Completed Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.
Condition: Alzheimer Disease
Interventions: Biological: Placebo;   Biological: CAD106
7 Recruiting BIOFLOW III Asia Registry
Conditions: Coronary Artery Disease;   Myocardial Ischemia;   Diabetes Mellitus Type 1 or 2
8 Completed Virtual Coronary Intervention and Non-invasive Fractional Flow Reserve (FFR)
Condition: Coronary Artery Disease
9 Recruiting Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets
Condition: Coronary Artery Disease
Intervention: Device: platinum chromium everolimus-eluting stent (PROMUS Element by Boston Scientific, Massachusetts)
10 Terminated Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Condition: Coronary Artery Disease
Interventions: Drug: Apadenoson SPECT-MPI;   Drug: Adenosine SPECT-MPI
11 Completed Computed Tomography Angiography Prediction Score for Percutaneous Revascularization of Chronic Total Occlusions
Condition: Coronary Artery Disease
Intervention: Procedure: PCI of CTO
12 Active, not recruiting The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Plus;   Device: SYNERGY
13 Active, not recruiting
Has Results
RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent
Conditions: Arterial Occlusive Diseases;   Myocardial Ischemia;   Cardiovascular Diseases;   Coronary Artery Disease
Intervention: Device: MDT-4107 Drug Eluting Stent
14 Completed Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
Conditions: Myocardial Infarction;   Coronary Artery Disease
Intervention: Drug: Intra-coronary infusion
15 Unknown  Could Non-invasive Biochemical, Image or Physiological Index Predict Significant Coronary Arterial Stenosis in Symptomatic Adults?
Condition: Coronary Heart Disease
Interventions: Radiation: coronary calcium score measurement;   Biological: high sensitivity C reactive protein measurement;   Procedure: ankle brachial index measurement
16 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
17 Completed Rotational Atherectomy Prior to Taxus Stent
Condition: Complex Calcified Coronary Lesions
Interventions: Procedure: Rotational Atherectomy + PES;   Procedure: Standard Treatment (PES without Rotational Atherectomy)
18 Completed Endocardial Stem Cells Approach Efficacy
Condition: Myocardial Ischemia
Intervention: Procedure: Autologous bone marrow mononuclear stem cells or peripheral blood stem cells
19 Completed TomVasc - Vascular Effects of Tomato Extract
Conditions: Ischemic Heart Disease;   Transient Ischemic Attack;   Stroke;   Peripheral Vascular Disease
Interventions: Dietary Supplement: Ateronon;   Dietary Supplement: Placebo
20 Completed Mesenchymal Stem Cells and Myocardial Ischemia
Conditions: Chronic Myocardial Ischemia;   Left Ventricular Dysfunction
Intervention: Genetic: Mesenchymal stem cells

Indicates status has not been verified in more than two years